Herring WL, Gould IG, Wittrup-Jensen V, Ertle J, Kuti E, Wolowacz S. Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomes. J Comp Eff Res. 2022 Dec 1;11(18):1349-63. doi: 10.2217/cer-2021-0194
Mogle J, Hill NL, Bratlee-Whitaker E, Bhargava S. Within-person associations of self-reports of memory impairment and depressive symptoms in older adults: moderation of relationships over time by personality. J Gerontol B Psychol Sci Soc Sci. 2022 Feb 3;77(2):300-11. doi: 10.1093/geronb/gbab080
Hill NL, Mogle J, Bhargava S, Whitaker E, Bhang I, Capuano AW, Arvanitakis Z, Bennett DA, Barnes LL. Differences in the associations between memory complaints and depressive symptoms among black and white older adults. J Gerontol B Psychol Sci Soc Sci. 2020 May 9;75(4):783-91. doi: 10.1093/geronb/gby091
Joshi K, Muser E, Xu Y, Schwab P, Datar M, Suehs B. Adherence and economic impact of paliperidone palmitate versus oral atypical antipsychotics in a Medicare population. J Comp Eff Res. 2018 Aug;7(8):723-35. doi: 10.2217/cer-2018-0003
Meyers J, Gajria K, Candrilli SD, Fridman M, Sikirica V. The impact of adjunctive guanfacine extended release on stimulant adherence in children/adolescents with attention-deficit/hyperactivity disorder. J Comp Eff Res. 2017 Mar;6(2):109-25. doi: 10.2217/cer-2016-0039